Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes

J Diabetes. 2016 Jan;8(1):165. doi: 10.1111/1753-0407.12330. Epub 2015 Dec 7.

Authors

Hadi Harati¹, Vandhna Sharma¹, Abbas Motazedi¹

Affiliation

¹ Internal Medicine Department, Providence Hospital, Washington, DC, USA.

PMID: 26211700
DOI: 10.1111/1753-0407.12330

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Canagliflozin / adverse effects*
Diabetes Mellitus, Type 1 / drug therapy*
Diabetic Ketoacidosis / chemically induced*
Female
Humans
Hypoglycemic Agents / adverse effects*
Male
Middle Aged
Prognosis
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Hypoglycemic Agents
SLC5A2 protein, human
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin